Genome Sequencing during a Patient's Journey through Cancer

N Engl J Med. 2019 Nov 28;381(22):2145-2156. doi: 10.1056/NEJMra1910138.

Authors

Jyoti Nangalia¹, Peter J Campbell¹

Affiliation

¹ From the Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, and Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research, the Department of Haematology, University of Cambridge, and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge - all in the United Kingdom.

PMID: 31774959
DOI: 10.1056/NEJMra1910138

No abstract available

Publication types

Review
Video-Audio Media

MeSH terms

Genome
Germ-Line Mutation
Humans
Interviews as Topic
Mutation*
Neoplasms / genetics*
Precision Medicine
Risk Assessment / methods
Whole Genome Sequencing* / methods

Grants and funding